Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Methadone Monitoring for Insights Into Adverse Events
This clinical trial update reports the completed results of a methadone monitoring study aimed at understanding adverse events in patients w…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Comparison of Buprenorphine and Methadone - 3 [Phase 2]
A Phase 2 trial comparing buprenorphine and methadone for opioid use disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder [Phase 1]
This Phase 1 study evaluated the pharmacokinetics, safety, and tolerability of three different molecular-weight formulations of depot bupren…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Activity Monitoring Assessment of Opiate Withdrawal - 4 [Phase 2]
Phase 2 trial evaluating activity monitoring for opiate withdrawal in opioid-related disorders has completed.
-
FDA approval · 2017-01-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride from VistaPharm, LLC under the ANDA pathway.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Transfer of Subjects From Subutex/Suboxone to RBP-6300 [Phase 2]
The document reports a Phase 2 study update. It describes the transfer of subjects from buprenorphine formulations Subutex/Suboxone to the l…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating buprenorphine/naloxone for opioid use disorder.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 [Phase 2]
A Phase 2 trial evaluating buprenorphine/naloxone for opiate-dependence treatment has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure [NA]
The RESPECT-PLUS trial evaluating services for infants with prenatal opiate exposure has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Tramadol to Reduce Opioid Withdrawal Symptoms [Phase 2]
Phase 2 clinical trial evaluating tramadol for reducing opioid withdrawal symptoms in people with opioid use disorder; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 [Phase 2]
This Phase 2 trial evaluated tiagabine for cocaine use disorder in individuals maintained on methadone and has completed. The study was spon…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 [Phase 2]
A Phase 2 clinical trial tested whether dextromethorphan influences opioid tolerance in methadone-maintained patients and has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 [Phase 2]
A Phase 2 trial update evaluating the efficacy of methadyl acetate (LAAM) in combination with contingency management for treating dual opioi…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens [Phase 2]
Phase 2 trial completed comparing three dosing regimens for heroin/opioid dependence to evaluate efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 [Phase 2]
This clinical trial update reports completion of a Phase 2 study evaluating buprenorphine/naloxone for treatment of opioid use disorder (opi…
-
FDA approval · 2017-01-12FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for SUBOXONE (buprenorphine hydrochloride/naloxone hydrochloride) submitted by Indivior Inc.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Addition of Naltrexone to Methadone Taper [Phase 2]
A Phase 2 clinical trial evaluating the addition of naltrexone to a methadone taper for heroin dependence and related opioid/substance use d…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 [Phase 3]
A Phase 3 trial comparing two taper schedules for buprenorphine/naloxone (Suboxone) in individuals with opioid use disorder; the study has c…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 [Phase 1]
Phase 1 trial evaluating buprenorphine and naloxone in individuals with opioid-related disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Lofexidine for Opiate Withdrawal - 1 [Phase 3]
Phase 3 clinical trial of lofexidine for opiate withdrawal sponsored by NIDA has completed. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 [Phase 2]
This document provides an update on a Phase 2 trial evaluating buprenorphine maintenance dosing schedules and treatment settings for opioid-…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 [Phase 3]
Phase 3 clinical trial of buprenorphine/naloxone for opioid-dependent adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 [Phase 1, Phase 2]
This clinical trial update reports a comparison of buprenorphine formulations (sublingual tablet vs. solution) for opioid-related disorders …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Buprenorphine Maintenance for Opiate Dependence - 6 [Phase 2]
Phase 2 trial update on buprenorphine maintenance for opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 [Phase 1]
Phase 1 clinical trial evaluating lofexidine for the treatment of opioid withdrawal has completed.